Agilus Diagnostics Launches Anti-MCV Antibody Test in Collaboration with Sebia to Enable Early RA Diagnosis
New Delhi, July 15, 2025 – Agilus Diagnostics, in collaboration with Sebia, has launched the Anti-MCV (anti–mutated citrullinated vimentin) antibody test in India. Developed by Sebia, this advanced diagnostic tool…